Filing Details
- Accession Number:
- 0001209191-12-018191
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-14 16:19:30
- Reporting Period:
- 2012-03-09
- Filing Date:
- 2012-03-14
- Accepted Time:
- 2012-03-14 15:19:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1338042 | Aegerion Pharmaceuticals Inc. | AEGR | Pharmaceutical Preparations (2834) | 202960116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227759 | Advent International Llc | C/O Advent International Corporation 75 State Street, 29Th Floor Boston MA 02109 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-03-09 | 98,897 | $15.87 | 2,430,765 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- These securities are indirectly beneficially owned in the following capacity: as General Partner of AHLS III GP Limited partnership which in turn is the General Partner of Advent Healthcare and Life Sciences III Limited Partnership and Advent Healthcare and Life Sciences III-A Limited Partnership.